share_log

瑞科生物-B:自願公告 本公司新佐劑重組帶狀疱疹疫苗REC610在菲律賓臨床試驗期中分析取得積極結果

RECBIO-B: VOLUNTARY ANNOUNCEMENT POSITIVE RESULTS IN THE INTERIM ANALYSIS OF THE CLINICAL TRIAL OF THE COMPANY''S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 IN THE PHILIPPINES

香港交易所 ·  Dec 28, 2023 23:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more